Cancer
- YOSHINO Y, Furusawa A, Nara K, Taguchi A, et al
Optimizing treatment for platinum-resistant ovarian clear cell carcinoma:
Efficacy of gemcitabine and combination therapy with bevacizumab.
Cancer. 2025;131:e70071.
Curr Treat Options Oncol
- POPAT V, Han E
From Fallopian Tube to Ovarian Cancer: Understanding the Evaluation and
Management of Serous Tubal Intraepithelial Carcinoma Lesions.
Curr Treat Options Oncol. 2025 Sep 5. doi: 10.1007/s11864-025-01346.
Gynecol Oncol
- REBOUILLAT C, Pomel C, Bourdel N, Mimoun C, et al
Diagnostic laparoscopy and cytoreduction surgery in ovarian cancer FIGO III-IV:
The impact on survival of one-stage versus two-stage sequence.
Gynecol Oncol. 2025;201:167-175.
- CHIAPPINELLI KB, Christie EL, Padmanabhan A
Biology of ovarian cancer: Models, microenvironment, and therapeutics: 15th
Biennial Rivkin Center Ovarian Cancer Research Symposium.
Gynecol Oncol. 2025;201:160-163.
Hum Pathol
- LEENEN S, Kooreman L, Bulten J, Esch EMGV, et al
The occurrence and histopathological recognition of atypical endometriosis in
patients with ovarian endometriosis - a retrospective cohort study.
Hum Pathol. 2025 Jul 22:105875. doi: 10.1016/j.humpath.2025.105875.
Int J Gynaecol Obstet
- YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
Immune checkpoint inhibitors in gynecologic oncology: Current status and
perspectives.
Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
- RENZ M, Friedlander M, Berek JS
Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.
Int J Gynaecol Obstet. 2025;171 Suppl 1:6-35.
- MCCLUGGAGE WG
New histopathological and molecular findings in gynecological cancers.
Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016